证券代码：601298 证券简称：青岛港 公告编号：临 2026-002 青岛港国际股份有限公司 2025 年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 本公告所载青岛港国际股份有限公司（以下简称"公司"）2025年度主要财务 数据为初步核算数据，未经会计师事务所审计，具体数据以公司2025年年度报告 中披露的数据为准，提请投资者注意投资风险。如无特指，以下"元"均指人民币 元。 一、2025年度主要财务数据和指标 单位：万元 币种：人民币 | 项目 | 本报告期 | 上年同期 | 增减变动幅度（%） | | | --- | --- | --- | --- | --- | | 营业总收入 | 1,880,632 | 1,894,100 | -0.7 | | | 营业利润 | 711,081 | 707,346 | 0.5 | | | 利润总额 | 712,870 | 706,779 | 0.9 | | | 归属于上市公司股东的 净利润 | 527,151 | 523,490 | 0.7 | | | 归属于上 ...

Financial Performance - The company achieved total operating revenue of RMB 20,323,457.38 million, an increase of 11.62% compared to the same period last year [3]. - Net profit attributable to shareholders of the listed company was RMB 1,252,720.11 million, a decrease of 3.88% year-on-year [4]. - Basic earnings per share decreased to RMB 3.99, down 3.86% from RMB 4.15 in the previous year [3]. - The decline in net profit was primarily influenced by the downward trend in chemical product prices [4]. - The weighted average return on net assets decreased by 1.85 percentage points to 12.44% [3]. Assets and Equity - Total assets at the end of the reporting period reached RMB 32,301,053.95 million, up 10.12% from the beginning of the period [4]. - Shareholders' equity attributable to the listed company increased by 14.46% to RMB 10,830,545.95 million [4]. Strategic Initiatives - The company emphasized a management theme of "transformation year" to address global uncertainties and increased R&D investment [4]. - The company successfully launched multiple new facilities and expanded its global market presence [4]. Cautionary Notes - The company warns that the financial data presented is preliminary and subject to audit, advising investors to be aware of investment risks [4].

Financial Performance - The company reported significant financial metrics, including total revenue and net profit, which are detailed in the financial report section[14]. - The company's operating revenue for 2025 was CNY 4,495,014,982.70, a decrease of 11.34% compared to CNY 5,069,807,068.71 in 2024[21]. - The net profit attributable to shareholders for 2025 was CNY 31,787,194.50, representing a 50.23% increase from CNY 21,159,442.80 in 2024[21]. - The net cash flow from operating activities decreased by 31.83% to CNY 231,548,889.20 in 2025 from CNY 339,645,265.53 in 2024[21]. - The total assets at the end of 2025 were CNY 9,405,983,870, a decrease of 13.58% from CNY 10,884,577,900 at the end of 2024[21]. - The basic earnings per share for 2025 was CNY 0.02, a 100% increase from CNY 0.01 in 2024[21]. - The company reported a significant decline in non-recurring profit, with a net profit of CNY 38,427,377.41 in 2025, down 99.36% from CNY 19,275,270.52 in 2024[21]. - The company achieved operating revenue of CNY 4.495 billion, a year-on-year decrease of 11.34%[68]. - Operating costs amounted to CNY 4.102 billion, down 11.12% year-on-year[68]. - The net profit attributable to shareholders increased by 50.23% to CNY 0.32 billion[68]. Shareholder Information - The company plans not to distribute cash dividends, issue bonus shares, or increase capital from reserves[6]. - The company reported a net profit attributable to the parent company of ¥31.79 million for 2025, but the undistributed profits were negative at -¥102,027.47 million for the parent company and -¥139,860.99 million for the consolidated financial statements, leading to no cash dividends being distributed[155]. - The total number of common shareholders at the end of the reporting period was 44,348, an increase from 41,666 at the end of the previous month, representing a growth of approximately 6.4%[182]. - The largest shareholder, Luzhou Tianhua (Group) Co., Ltd., holds 15.09% of shares, totaling 236,550,393 shares, with no changes during the reporting period[182]. - The second-largest shareholder, Luzhou Industrial Development Investment Group Co., Ltd., owns 14.84% of shares, amounting to 232,664,610 shares, also with no changes[182]. - The company has a controlling shareholder, which is a local state-owned entity, indicating a stable ownership structure[184]. Business Operations - The company has expanded its business scope to include the production of hazardous chemicals and fertilizers, as approved by relevant authorities[19]. - The company continues to engage in the production and sales of chemical products, including urea and methanol, which are critical for agricultural and industrial applications[26]. - The company is actively conducting research on new technologies in fine chemicals, new materials, and new energy, establishing a technology innovation incubation platform to reduce technology transfer costs and market risks[31]. - The company is focusing on the development of new products and technologies, emphasizing exploratory innovation to drive industry growth[57]. - The company is transitioning from traditional fertilizer production to "new agriculture, new materials, and new energy" to enhance core competitiveness and sustainable development[57]. Environmental and Safety Compliance - The company has received environmental impact report approvals for new projects, including a 100,000 tons/year green fine chemical project[46]. - The company is committed to achieving a 100% compliance rate for wastewater discharge and has implemented 15 environmental facility upgrades[70]. - The company aims to enhance its safety and environmental protection measures, ensuring a 100% compliance rate for emissions and implementing a carbon footprint tracking system[106]. - The company is addressing safety and environmental risks by enhancing safety management and investing in advanced monitoring technologies[114]. Research and Development - The company completed 24 technology innovation projects and applied for 26 patents, with 17 patents granted[63]. - The company launched 95 technology innovation projects in 2025, achieving 9 results and successfully converting 10 technologies[71]. - The company is developing a specialized compound fertilizer for eucalyptus, which has completed product trial production[87]. - A new process for producing potassium nitrate is under research, with pilot tests ongoing to establish a proprietary technology[87]. - The company's R&D investment increased by 9.39% to approximately ¥113.98 million in 2025, representing 2.54% of total revenue[89]. Financial Management - The company has a clear cash dividend policy that complies with its articles of association and shareholder resolutions, ensuring reasonable returns to investors while maintaining sustainable development[154]. - The internal control system has been continuously improved and optimized to adapt to changing external environments and internal management requirements, ensuring effective execution without significant omissions[156]. - The internal control evaluation report indicated that 100% of the total assets and operating income of the evaluated units were included in the consolidated financial statements[157]. - The internal control audit report issued a standard unqualified opinion, confirming consistency with the board's self-evaluation report[159]. Governance and Management - The company has a structured approach to remuneration, ensuring alignment with performance and company policies[138]. - The company’s board and senior management remuneration is determined based on the labor and personnel wage system, individual performance, and evaluation results[138]. - The company has established a performance evaluation system that incentivizes contributions from research and technical personnel, as well as management staff[151]. - The company has a dedicated investor relations management responsible for information disclosure and shareholder communication[123]. - The company has experienced changes in its board of directors, with an independent director leaving after reaching the term limit, and a new independent director being elected[131]. Community Engagement - The company invested over 600,000 yuan in social responsibility initiatives, including charitable donations and educational support[162]. - The company organized a "charity one-day donation" event, raising a total of 208,000 yuan from employees[162]. - The company provided 70.5 tons of fertilizer to five supported villages to assist farmers during the spring plowing season[163]. - The company purchased over 6,000 kg of winter bamboo shoots and 4,700 kg of ginger from local farmers, directly contributing to their income[163].

山推工程机械股份有限公司 2025 年年度报告 （000680） 二○二六年三月 山推工程机械股份有限公司 2025 年年度报告全文 3、所有董事均已出席了审议本报告的董事会会议。 4、本年度报告涉及未来计划等前瞻性陈述，不构成公司对投资者的实质承诺，投资者 及相关人士均应当对此保持足够的风险认识，并且应当理解计划、预测与承诺之间的差异。 5、公司在本年度报告第三节管理层讨论与分析中，描述了影响公司未来发展战略和经 营目标的风险因素及对策，敬请查阅。《中国证券报》、《证券时报》和巨潮资讯网 （www.cninfo.com.cn）为公司信息披露指定媒体，公司所有信息均以在上述指定媒体刊登 的信息为准，敬请投资者注意投资风险。 6、公司经本次董事会审议通过的利润分配预案为：以公司总股本 1,500,142,612 股扣 除回购专用证券账户持有的公司 14,842,772 股股份后的 1,485,299,840 股为基数，向全体 股东每 10 股派发现金红利 1.0 元（含税），送红股 0 股（含税），不以公积金转增股本。 1 山推工程机械股份有限公司 2025 年年度报告 第一节 重要提示、目录和释义 1、公司董 ...

深圳贝仕达克技术股份有限公司 2025 年年度报告全文 深圳贝仕达克技术股份有限公司 2025 年年度报告 2026-008 2026 年 3 月 16 日 深圳贝仕达克技术股份有限公司 2025 年年度报告全文 2025 年年度报告 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律 责任。 公司负责人肖萍、主管会计工作负责人詹庆林及会计机构负责人（会计 主管人员）詹庆林声明：保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 2025 年度，公司实现营业收入 83,840.68 万元，同比下降 1.52%；归属 于上市公司股东的净利润 1,217.40 万元，同比下降 77.97%；归属于上市公司 股东的扣除非经常性损益的净利润 1,152.19 万元，同比下降 78.15%。 （一）报告期内，公司归属于上市公司股东的净利润同比大幅下滑，主 要原因系： 1、资产减值准备计提增加，对当期业绩产生不利影响。 根据《企业会计准则》等相关规定，基于谨慎性原则，公司结合 ...

佳沃食品股份有限公司 2025 年年度报告全文 佳沃食品股份有限公司 2025 年年度报告 2026-010 二○二六年三月 1 佳沃食品股份有限公司 2025 年年度报告全文 2025 年年度报告 第一节 重要提示、目录和释义 公司董事会及董事、高级管理人员保证年度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律 责任。 公司负责人陈绍鹏、主管会计工作负责人邱春燕及会计机构负责人(会计 主管人员)邱春燕声明：保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 公司原子公司北京佳沃臻诚科技有限公司（以下简称"北京臻诚"）近 年来连续亏损，公司于 2025 年 6 月完成重大资产重组交割程序，依据《企业 会计准则第 33 号—合并财务报表》规定，将原子公司北京臻诚期初至处置日 的收入、费用、利润纳入合并利润表，本报告期包含原子公司北京臻诚 2025 年 1-6 月损益，自 2025 年下半年起原子公司北京臻诚不再纳入公司合并报表， 从而导致收入同比下降，净利润大幅减亏，同时实现了净资产转正。 公司狭鳕鱼业务原料价格持续飙升，市场对 ...

上海合晶硅材料股份有限公司2025 年年度报告 公司代码：688584 公司简称：上海合晶 上海合晶硅材料股份有限公司 2025 年年度报告 1 / 241 上海合晶硅材料股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司上市时未盈利且尚未实现盈利 □是 √否 □适用 √不适用 三、重大风险提示 报告期内，不存在对公司生产经营产生实质性影响的特别重大风险。公司已在报告中详细描 述可能存在的相关风险及应对措施，敬请查阅本报告"第三节 管理层讨论与分析"之"四、风险 因素"部分内容。 四、公司全体董事出席董事会会议。 五、立信会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 六、公司负责人毛瑞源、主管会计工作负责人方时彬及会计机构负责人（会计主管人员）陈重光 声明：保证年度报告中财务报告的真实、准确、完整。 七、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司于2026年3月13日召开第三届董事会第六次会议，审议通过《2025年度利 ...

合富（中国）医疗科技股份有限公司2025 年年度报告 公司代码：603122 公司简称：合富中国 合富（中国）医疗科技股份有限公司 2025 年年度报告 1 / 195 合富（中国）医疗科技股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、毕马威华振会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人王琼芝、主管会计工作负责人王琼芝及会计机构负责人（会计主管人员）高恒正 声明：保证年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 经毕马威华振会计师事务所（特殊普通合伙）审计确认，公司2025年度实现归属于上市公司 股东的净利润为-3,364.30 万元，母公司净利润为-2,715.36万元。截至2025年12月31日，公司合并 报表累计未分配利润为4,392.52万元，母公司报表累计未分配利润为6,484.15万元。2025年，受行 业环境波动、市场 ...

Financial Projections - The company expects a total profit of between 10 million and 14 million yuan for the year 2025, with a net profit attributable to shareholders of the parent company estimated between 6 million and 8 million yuan[3]. - The net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, is projected to be between -6.5 million and -4.5 million yuan[3]. - The expected operating revenue for 2025 is between 450 million and 490 million yuan, with revenue after excluding unrelated business income estimated between 420 million and 460 million yuan[3]. - The net assets attributable to shareholders of the listed company are expected to be between 950 million and 970 million yuan by the end of 2025[3]. - In the previous year, the total profit was 8.5466 million yuan, and the net profit attributable to shareholders of the parent company was 5.1111 million yuan[7]. - The operating revenue for the previous year was 360.6095 million yuan, with revenue after excluding unrelated business income at 285.1295 million yuan[8]. Business Development - The company has increased investment in product research and development and actively expanded both domestic and international markets, resulting in revenue growth across various business segments[9]. - The electronic communication business has seen an increase in mobile phone orders due to rising customer demand and market expansion efforts[9]. Delisting Risk - The company’s stock has been subject to delisting risk warnings due to negative net profit and operating revenue below 300 million yuan for the previous year[11]. - The company plans to apply for the removal of the delisting risk warning if it meets the necessary conditions after the 2025 annual report is disclosed[11].

宝胜科技创新股份有限公司2025 年年度报告 公司代码：600973公司简称：宝胜股份 宝胜科技创新股份有限公司 2025 年年度报告 1 / 214 宝胜科技创新股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、 大信会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人生长山、主管会计工作负责人张啸龙及会计机构负责人（会计主管人员）张庶人 声明：保证年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 经大信会计师事务所（特殊普通合伙）审计，截至2025年12月31日，公司母公司未分配利润 -171,745,454.41元。鉴于公司2025年度亏损且母公司未分配利润为负值，综合考虑公司长远发展 战略及短期经营状况，结合宏观经济环境形势下经营资金周转安排，根据《公司法》、《上市公 司监管指引第3号——上市公司现金分红》等有关法律规定及《公司章程》的相关 ...